BP made a big deal of repositioning itself as “Beyond Petroleum”. Then-CEO John Browne’s attempt to embrace lower-carbon ...
We recently published a list of 10 Firms Hit Hard in Thursday’s Trading. In this article, we are going to take a look at ...
TotalEnergies CEO Patrick Pouyanne said he rejected opportunities to become a long-term customer of Venture Global's U.S.
TotalEnergies CEO Patrick Pouyanne has unveiled plans to expand the company's investment in the US liquefied natural gas (LNG) market over the next decade. This move aims to strengthen TotalEnergies' ...
In a report released today, Biraj Borkhataria from RBC Capital maintained a Hold rating on BP p.l.c. (BP – Research Report), with a price ...
Another day, another chunky Italian bank merger. On the face of it, Thursday’s decision by $9 billion BPER to lob in a $4.5 ...
The burgeoning trade war between the United States and China has caught American gas exporters in the crossfire as they face ...
Steve Schwarzman knows a thing or two about wealth. It’s no wonder that Blackstone , the investing colossus he runs, found a ...
Japan's SoftBank is reportedly close to becoming the biggest investor in generative artificial intelligence leader OpenAI, ...
What are the Magnificent Seven stocks? How much market cap weighting do AAPL, MSFT, GOOGL, AMZN, META, TSLA and NVDA have on ...
Debt-funded buyouts are expected to rebound this year as borrowing costs decline, enabling private equity firms to finance deals cheaply and complete more acquisitions. According to the terms of the ...
Neurocrine stock took a hit late Thursday after the biotech company issued a light 2025 outlook for its drug, Ingrezza.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results